Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

Neurology

Volumn 81, Issue 14, 2013, Pages 1191-1196

  Cernuda Morollón, Eva ^a   Larrosa, Davinia ^a   Ramón, César ^a   Vega, Juan ^a   Martínez Camblor, Pablo ^b   Pascual, Julio ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Oficina de Investigación Biosanitaria OIB de Asturias and Universidad Autonoma de Chile   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CALCITONIN GENE RELATED PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUNARIZINE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGE; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPRESSION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISODIC CLUSTER HEADACHE; EPISODIC MIGRAINE; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TRANSFORMED MIGRAINE;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; CHRONIC DISEASE; CLUSTER HEADACHE; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; UP-REGULATION; YOUNG ADULT;

EID: 84888324384     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a6cb72     Document Type: Article

References (31)

1. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26:742-746.
2. Moskowitz MA. The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991;41: 182-186.
3. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56. (Pubitemid 23009909)
4. Goadsby PJ, Edvisnson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187. (Pubitemid 20244522)
5. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev 2005;48:438-456. (Pubitemid 40731510)
6. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996;384:560-564. (Pubitemid 26415932)
7. Seybold VS. The role of peptides in central sensitization. Handb Exp Pharmacol 2009:451-491.
8. Benarroch EE. CGRP: sensory neuropeptide with multiple neurologic implications. Neurology 2011;77:281-287.
9. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 2010;6:573-582.
10. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002;22:54-61. (Pubitemid 34626025)
11. Olesen J, Diener HC, Husstedt IW, et al. Calcitonin generelated peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350:1104-1110. (Pubitemid 38298990)
12. Edvinsson L, Linde M. New drugs in migraine treatment and prophylaxis: Telcagepant and topiramate. Lancet 2010; 376:645-655.
13. Sarchielli P, Pini LA, Zanchin G, et al. Clinical-biochemical correlates of migraine attacks with rizatriptan responders and non-responders. Cephalalgia 2006;26:257-265.
14. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schiffter S, Olesen J. No increase of calcitonin-gene related peptide in jugular blood during migraine. Ann Neurol 2005;58:561-568. (Pubitemid 41377219)
15. Edvinsson L, Ekman R, Goadsby PJ. Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia 2010;30:761-766.
16. Gallai V, Sarchielli P, Floridi A, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 1995;15:384-390.
17. Rodríguez-Osorio X, Sobrino T, Brea D, Martínez F, Castillo J, Leira R. Endothelial progenitor cells: A new key for endothelial dysfunction in migraine. Neurology 2012;79:474-479.
18. Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakshima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 2007;128:209-214. (Pubitemid 46367415)
19. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J. Evidence for increased plasma levels of calcitonin generelated peptide in migraine outside of attacks. Pain 2000; 86:133-138. (Pubitemid 30211712)
20. Cady RK, Vause CV, Ho TW, Bigal ME, Durham PL. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan. Headache 2009;49:1258-1266.
21. Jang MU, Park JW, Kho HS, Chung SC, Chung JW. Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 2011;17:187-193.
22. Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology 2001;57:132-134. (Pubitemid 32634864)
23. Ashina M, Bendtsen L, Jensen R, Schifter S, Jansen-Olesen I, Olesen J. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 2000; 55:1335-1340.
24. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8:136-142. (Pubitemid 34155124)
25. Kelman L. The aura: A tertiary care study of 952 migraine patients. Cephalalgia 2004;24:728-734. (Pubitemid 39209076)
26. Li J, Vause CV, Durham PL. Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 2008;1196:22-32.
27. Messlinger K, Lennerz JK, Eberhardt M, Fischer MJM. CGRP and NO in the trigeminal system: mechanisms and role in headache generation. Headache 2012;52:1411-1427.
28. Giniatullin R, Nistri A, Fabbretti E. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol Neurobiol 2008;37:83-90.
29. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitization. Lancet Neurol 2009;8:679-690.
30. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache: neuropeptide changes and effects of acute attack therapies. Brain 1994;117:427-434.
31. Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S. Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 2005;25:700-703. (Pubitemid 41208311)